PUBLISHER: TechNavio | PRODUCT CODE: 1398147
PUBLISHER: TechNavio | PRODUCT CODE: 1398147
The anaplastic thyroid cancer drugs market is forecasted to grow by USD 300.7 mn during 2023-2028, accelerating at a CAGR of 6.41% during the forecast period. The report on the anaplastic thyroid cancer drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by high prevalence of thyroid cancer, introduction of targeted therapies, and rising geriatric population.
Market Scope | |
---|---|
Base Year | 2023 |
End Year | 2028 |
Series Year | 2024-2028 |
Growth Momentum | Accelerate |
YOY 2024 | 5.55% |
CAGR | 6.41% |
Incremental Value | $300.7mn |
Technavio's anaplastic thyroid cancer drugs market is segmented as below:
By End-user
By Product
By Geographical Landscape
This study identifies the growing awareness of thyroid cancer as one of the prime reasons driving the anaplastic thyroid cancer drugs market growth during the next few years. Also, strong pipeline in the treatment of anaplastic thyroid cancer and favorable reimbursement policies for chemotherapy will lead to sizable demand in the market.
The report on the anaplastic thyroid cancer drugs market covers the following areas:
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading anaplastic thyroid cancer drugs market vendors that include Bayer AG, Bristol Myers Squibb Co., Daiichi Sankyo Co. Ltd., Eisai Co. Ltd., Exelixis Inc., Merck KGaA, Novartis AG, and Verastem Inc.. Also, the anaplastic thyroid cancer drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Exhibits: